查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1971524

硅胶非正规敷料市场 - 全球产业规模、份额、趋势、机会、预测、区域及竞争格局（2021-2031年）

Non-Silicone Foam Dressings Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 188 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球非硅泡棉敷料市场预计将从 2025 年的 5.5212 亿美元成长到 2031 年的 7.2772 亿美元，复合年增长率为 4.71%。

这些产品通常由聚氨酯泡棉和丙烯酸黏合剂或非黏合剂介面组成，旨在促进潮湿环境下的创伤治疗，同时有效吸收中度至重度渗出液。与硅基替代品相比，其成本优势是推动该市场发展的主要因素，因此在预算紧张的医疗保健系统中备受青睐。慢性伤口（例如糖尿病溃疡）在全球发病率的上升进一步刺激了这一需求。例如，英国糖尿病协会2024年5月发布的报告指出，过去五年中，青少年第二型糖尿病的诊断数量增加了约40%，凸显了易患该疾病的人群日益增多，而有效的伤口管理至关重要。

市场概览
预测期 2027-2031
市场规模：2025年 5.5212亿美元
市场规模：2031年 7.2772亿美元
复合年增长率：2026-2031年 4.71%
成长最快的细分市场
最大的市场 北美洲

儘管存在这些成长要素，但市场仍面临与皮肤健康相关的重大挑战。这是因为刺激性强的非硅酮黏合剂，与温和的硅酮产品不同，在移除时可能会造成疼痛和创伤。与医用黏合剂相关的皮肤损伤风险促使临床医生和患者更倾向于使用硅酮敷料，从而限制了非硅酮产品的普及。在敏感脆弱肌肤的应用中，这种趋势尤其明显，因为在这些情况下，最大限度地减少创伤至关重要。因此，儘管成本效益吸引了市场关注，但皮肤损伤的可能性仍然是限制该细分市场在高风险护理环境中扩张的主要阻碍因素。

市场驱动因素

全球慢性伤口（尤其是糖尿病足溃疡）盛行率的不断上升，是推动全球非硅泡棉敷料市场成长要素。糖尿病患者由于神经病变和血液作用不良等併发症，容易出现难癒合的溃疡，因此迫切需要能够吸收大量渗出液的敷料。非硅泡棉敷料因其比硅基敷料更经济实惠且具有更优异的引流性能，在这些情况下已广泛应用。这使得它们在拥有庞大患者群体的医疗系统中不可或缺。根据国际糖尿病联盟（IDF）于2025年4月更新的《糖尿病地图集》，目前全球约有5.89亿20至79岁的成年人患有糖尿病，这是一个庞大的患者群体，他们面临着发生溃疡的风险以及相关的创伤护理需求。

同时，人口老化显着推高了市场需求。老年人由于老龄化相关的皮肤脆弱和缺乏运动，特别容易患上静脉性腿部溃疡和压疮。这种人口结构的变化凸显了养老院和居家医疗机构对有效且经济的创伤护理解决方案的需求，使得非硅泡沫敷料成为治疗压疮的标准工具。根据世界卫生组织（世卫组织）于2025年10月发布的《老化与健康》概况介绍，预计到2050年，60岁及以上人口的比例将从2015年的12%几乎翻一番，达到22%。这种需求的成长与产业绩效密切相关。例如，史密斯医疗（Smith & Nephew）于2025年8月发布的《2025年第二季度和上半年财务业绩》显示，创伤护理业务部门的核心收入增长了2.6%，这主要得益于泡沫敷料产品线的销售增长。

市场挑战

全球非硅泡棉敷料市场成长的主要障碍是强力黏合剂造成的皮肤损伤风险，即医用黏合剂相关性皮肤损伤。与硅胶敷料温和的剥离方式不同，非硅敷料中常用的橡胶或丙烯酸类黏合剂形成的黏合力过强，会对娇嫩的皮肤组织造成损伤。移除这些敷料会导致皮肤表层剥落，造成剧烈疼痛和继发性伤口。这种损伤风险使得医护人员在为老年患者或皮肤脆弱的患者选择非硅敷料时犹豫不决，从而限制了此类产品在以皮肤保护为首要任务的临床环境中的应用。

这种犹豫不决极大地限制了非硅酮敷料的潜在市场，因为最需要泡沫敷料的患者群体通常具有不适合强力黏附的皮肤特性。考虑到需要长期伤口管理的患者数量庞大，而他们原本都是这些经济有效的解决方案的适用人群，这种限制的严重性就显而易见了。根据欧洲伤口管理协会的数据，到2024年，欧洲地区约有400万人患有慢性伤口。如此庞大的患者群体需要频繁更换敷料，这表明无法安全保护脆弱的皮肤直接阻碍了非硅酮敷料市场的成长潜力。

市场趋势

随着医疗系统将主动感染控制与液体管理并重，先进抗菌剂和生物活性剂的整合正在改变这一领域。这一趋势推动了含有银和聚六亚甲基双胍（PHMB）等活性剂的非硅泡沫敷料的研发，为慢性溃疡生物膜管理提供了一种比昂贵的硅基产品更具成本效益的替代方案。这些增值解决方案的发展势头在行业数据中显而易见。例如，根据史密斯医疗（Smith & Nephew）于2025年11月发布的2025年第三季财报，其先进伤口生物活性业务的核心收入增长了12.2%，显着高于其他业务板块，凸显了市场对化学活性敷料界面日益增长的需求。

同时，能够即时监测伤口的智慧感测器技术正在革新护理方式，它直接在敷料结构内进行预测性诊断。透过将微型感测器嵌入吸水泡沫基质中，这些新一代产品使临床医生能够远端监测水分和pH值等关键指标，从而减少可能进一步损伤脆弱皮肤的敷料更换频率。这项技术正迅速从实验阶段迈向临床应用，可望提早识别感染风险。正如2025年6月发表于《临床研究新闻》（Clinical Research News）题为“智能绷带技术：从动物模型到人体临床试验”的报导报道，一种新型智能绷带系统在人体临床试验中成功检测到与炎症和感染相关的生物标誌物，且检测时间比可见的临床症状出现时间提前1至3天。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球硅胶非成型敷料市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美硅胶非成型敷料市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲硅胶非成型敷料市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区硅酮非成型敷料市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲硅胶非成型敷料市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲硅胶非成型敷料市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球硅胶非成型敷料市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • MOlnlycke AB
  • Essity AB
  • Medline Industries, LP
  • Smith & Nephew Plc
  • Convatec Group Plc
  • 3M Company
  • Advancis Medical
  • Coloplast Corp
  • DermaRite Industries, LLC
  • Acto GmbH

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 27146

The Global Non-Silicone Foam Dressings Market is projected to expand from USD 552.12 Million in 2025 to USD 727.72 Million by 2031, achieving a CAGR of 4.71%. These products are typically constructed from polyurethane foam featuring either acrylic adhesives or non-adhesive interfaces, designed to effectively absorb moderate to heavy exudate while supporting moist wound healing. A primary driver for this market is the cost advantage these dressings offer over silicone-based alternatives, making them a preferred choice for budget-constrained healthcare systems. This demand is further amplified by the rising global incidence of chronic wounds, such as diabetic ulcers. For instance, a May 2024 report by Diabetes UK noted a nearly 40% increase in early-onset type 2 diabetes diagnoses over the past five years, highlighting a growing population vulnerable to conditions requiring efficient wound management.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 552.12 Million
Market Size 2031USD 727.72 Million
CAGR 2026-20314.71%
Fastest Growing Segment
Largest MarketNorth America

Despite these growth factors, the market faces significant hurdles related to skin integrity, as aggressive non-silicone adhesives can cause pain or trauma upon removal, unlike gentler silicone options. This risk of medical adhesive-related skin injury frequently leads clinicians and patients to favor silicone-based dressings, thereby limiting the adoption of non-silicone variants. This preference is particularly evident in applications involving sensitive or fragile skin, where minimizing trauma is essential. Consequently, while cost-efficiency drives market interest, the potential for skin damage remains a substantial restraint on the segment's expansion in high-risk care settings.

Market Driver

The escalating global prevalence of chronic wounds, especially diabetic foot ulcers, serves as a major growth catalyst for the Global Non-Silicone Foam Dressings Market. Individuals managing diabetes are particularly prone to developing non-healing ulcers due to complications like neuropathy and poor circulation, creating an urgent need for dressings that can handle significant exudate. Non-silicone foam dressings are widely utilized in these situations because they provide superior fluid handling at a lower cost than silicone alternatives, rendering them essential for healthcare systems dealing with high patient volumes. According to the International Diabetes Federation's 'Diabetes Atlas' update in April 2025, approximately 589 million adults aged 20-79 are currently living with diabetes worldwide, representing a vast patient base susceptible to ulceration and subsequent wound care requirements.

Simultaneously, the growing geriatric population significantly boosts market demand, as older adults are disproportionately susceptible to venous leg ulcers and pressure injuries due to age-related skin fragility and immobility. This demographic shift underscores the necessity for effective, budget-friendly wound care solutions in nursing homes and home healthcare environments, where non-silicone foams are a standard tool for treating bedsores. As stated in the World Health Organization's 'Ageing and Health' fact sheet from October 2025, the percentage of the global population over 60 is expected to nearly double from 12% in 2015 to 22% by 2050. This rising demand correlates with industry performance; for example, Smith & Nephew's 'Second Quarter and First Half 2025 Results' from August 2025 reported a 2.6% underlying revenue growth in their Advanced Wound Care business, driven specifically by gains in their foam dressing portfolio.

Market Challenge

The primary barrier hindering the growth of the Global Non-Silicone Foam Dressings Market is the risk of skin trauma associated with aggressive adhesives, known as medical adhesive-related skin injury. Unlike the gentle release provided by silicone interfaces, the rubber-based or acrylic adhesives typically used in non-silicone dressings often form a bond that is too strong for delicate tissue. Removing these dressings can strip the outer layer of the skin, resulting in significant pain and secondary wounding. This potential for damage discourages medical professionals from choosing non-silicone options for elderly patients or those with compromised skin integrity, effectively restricting the product's use in clinical settings where skin preservation is a priority.

This hesitation significantly limits the addressable market for non-silicone dressings, as the patient demographics most in need of foam dressings often exhibit skin characteristics that are incompatible with strong adhesion. The scale of this limitation becomes apparent when considering the vast number of patients requiring long-term wound management who would otherwise be candidates for these cost-effective solutions. According to the European Wound Management Association, nearly four million people in the European region were affected by chronic wounds in 2024. This substantial volume of patients requiring frequent dressing changes illustrates how the inability to safely accommodate fragile skin directly curbs the growth potential of the non-silicone segment.

Market Trends

The sector is being transformed by the integration of advanced antimicrobial and bioactive formulations, as healthcare systems increasingly prioritize active infection control alongside fluid management. This trend is driving the development of non-silicone foam dressings infused with agents such as silver or PHMB, providing a budget-conscious alternative for combating biofilm in chronic ulcers compared to premium silicone options. The momentum for these value-added solutions is evident in industry data; for instance, Smith & Nephew's 'Third Quarter 2025 Trading Report' from November 2025 indicated that their Advanced Wound Bioactives business achieved 12.2% underlying revenue growth, significantly outpacing other segments and highlighting the rising demand for chemically active dressing interfaces.

Concurrently, the adoption of smart sensor technologies for real-time wound monitoring is revolutionizing care by enabling predictive diagnostics directly within the dressing structure. By embedding micro-sensors into the absorbent foam matrix, these next-generation products allow clinicians to remotely monitor critical indicators like moisture and pH, reducing the frequency of dressing changes that can further damage fragile skin. This technology has rapidly advanced from experimental phases to clinical viability, offering the potential to preemptively identify infection risks. As reported by Clinical Research News in June 2025, in the article 'Smart Bandage Technology Advances from Animal Models to Human Clinical Testing', a human trial demonstrated that a new smart bandage system successfully detected biomarkers associated with inflammation and infection one to three days before the onset of visible clinical symptoms.

Key Market Players

  • MOlnlycke AB
  • Essity AB
  • Medline Industries, LP
  • Smith & Nephew Plc
  • Convatec Group Plc
  • 3M Company
  • Advancis Medical
  • Coloplast Corp
  • DermaRite Industries, LLC
  • Acto GmbH

Report Scope

In this report, the Global Non-Silicone Foam Dressings Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Non-Silicone Foam Dressings Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Non-Silicone Foam Dressings Market.

Available Customizations:

Global Non-Silicone Foam Dressings Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Non-Silicone Foam Dressings Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Region
    • 5.2.2. By Company (2025)
  • 5.3. Market Map

6. North America Non-Silicone Foam Dressings Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Non-Silicone Foam Dressings Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
    • 6.3.2. Canada Non-Silicone Foam Dressings Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
    • 6.3.3. Mexico Non-Silicone Foam Dressings Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast

7. Europe Non-Silicone Foam Dressings Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Non-Silicone Foam Dressings Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
    • 7.3.2. France Non-Silicone Foam Dressings Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
    • 7.3.3. United Kingdom Non-Silicone Foam Dressings Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
    • 7.3.4. Italy Non-Silicone Foam Dressings Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
    • 7.3.5. Spain Non-Silicone Foam Dressings Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast

8. Asia Pacific Non-Silicone Foam Dressings Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Non-Silicone Foam Dressings Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
    • 8.3.2. India Non-Silicone Foam Dressings Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
    • 8.3.3. Japan Non-Silicone Foam Dressings Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
    • 8.3.4. South Korea Non-Silicone Foam Dressings Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
    • 8.3.5. Australia Non-Silicone Foam Dressings Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast

9. Middle East & Africa Non-Silicone Foam Dressings Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Non-Silicone Foam Dressings Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
    • 9.3.2. UAE Non-Silicone Foam Dressings Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
    • 9.3.3. South Africa Non-Silicone Foam Dressings Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast

10. South America Non-Silicone Foam Dressings Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Non-Silicone Foam Dressings Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
    • 10.3.2. Colombia Non-Silicone Foam Dressings Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
    • 10.3.3. Argentina Non-Silicone Foam Dressings Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Non-Silicone Foam Dressings Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. MOlnlycke AB
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Essity AB
  • 15.3. Medline Industries, LP
  • 15.4. Smith & Nephew Plc
  • 15.5. Convatec Group Plc
  • 15.6. 3M Company
  • 15.7. Advancis Medical
  • 15.8. Coloplast Corp
  • 15.9. DermaRite Industries, LLC
  • 15.10. Acto GmbH

16. Strategic Recommendations

17. About Us & Disclaimer